Clinical Trial Update: Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for Cancer Therapy-Induced Thrombocytopenia (CTIT) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update: Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002) for cancer therapy-induced thrombocytopenia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Therapy-induced Thrombocytopenia
• Thrombocytopenia

Drugs mentioned

• Umbilical Cord Blood Megakaryocyte Injection (XJ-MK-002)

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Thrombocytopenia, Cancer | Phase 1 | Status: RECRUITING